Vanguard Growth ETF (VUG) Up By 43% From Its 52-Week Low Price

The Vanguard Growth ETF (VUG) has been rallying in recent weeks, and it is now up by more than 40% from its 52-week low price.

VUG Rallies By More Than 40% In Recent Weeks

The Vanguard Growth ETF (VUG) is one of the top funds providing investors with momentum at the moment. The ETF hit a 52-week high and is up by more than 43% from its 52-week low price of $218.28/share.

At the time of writing, VUG is trading at $312 per share, up by more than 40% from its 52-week low. The fund has performed excellently since the start of the year. Year-to-date, VUG is up by more than 24%, making it one of the top performers in the market. In the past year, the fund’s value has increased by nearly 40%.

The VUG ETF seeks to track the performance of the CRSP US Large Cap Growth Index. The index measures the investment returns of some of the large-cap growth stocks. The fund uses an indexing investment approach specially designed to track the performance of the index, which is mostly made up of the leading growth stocks in the United States.

The advisor investments all of its assets in the stocks that comprise the index, holding the stocks in approximately the same proportion as its weighting in the index. The VUG fund currently has more than $86 billion in assets under management and charges four basis points in annual fees.

VUG Could Rally Further

Despite rising by more than 40% over the past year, the VUG ETF has the potential to increase its value in recent months. The rally is mostly due to the excellent performance of the growth stocks in the United States, especially the pharmaceutical companies.

Moderna (MRNA) and Johnson & Johnson (JNJ) are some of the stocks the fund invests in, and they have been performing excellently in recent months, thanks to their huge role in rolling out the Covid-19 vaccines. As a result, VUG could rally higher in the coming weeks and months.